{"id":"https://openalex.org/W2030574136","doi":"https://doi.org/10.1111/j.1749-6632.2000.tb06711.x","title":"p53: A Potential Target Antigen for Immunotherapy of Cancer","display_name":"p53: A Potential Target Antigen for Immunotherapy of Cancer","publication_year":2000,"publication_date":"2000-06-01","ids":{"openalex":"https://openalex.org/W2030574136","doi":"https://doi.org/10.1111/j.1749-6632.2000.tb06711.x","mag":"2030574136","pmid":"https://pubmed.ncbi.nlm.nih.gov/10911916"},"language":"en","primary_location":{"id":"doi:10.1111/j.1749-6632.2000.tb06711.x","doi":"https://doi.org/10.1111/j.1749-6632.2000.tb06711.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1749-6632.2000.tb06711.x","pdf_url":null,"source":{"id":"https://openalex.org/S8802318","display_name":"Annals of the New York Academy of Sciences","issn_l":"0077-8923","issn":["0077-8923","1749-6632"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of the New York Academy of Sciences","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5011701229","display_name":"Rienk Offringa","orcid":"https://orcid.org/0000-0001-6310-1026","observed_orcids":["https://orcid.org/0000-0001-6310-1026"]},"institutions":[{"id":"https://openalex.org/I2800006345","display_name":"Leiden University Medical Center","ror":"https://ror.org/05xvt9f17","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2800006345"]}],"countries":["NL"],"is_corresponding":true,"raw_author_name":"RIENK OFFRINGA","raw_affiliation_strings":["Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, The Netherlands. R.Offringa@Immunohematology.MedFac.LeidenUniv.nl","Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, 2333ZA Leiden, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, The Netherlands. R.Offringa@Immunohematology.MedFac.LeidenUniv.nl","institution_ids":["https://openalex.org/I2800006345"]},{"raw_affiliation_string":"Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, 2333ZA Leiden, the Netherlands","institution_ids":["https://openalex.org/I2800006345"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069049117","display_name":"Michel Vierboom","orcid":"https://orcid.org/0000-0002-1865-7532","observed_orcids":["https://orcid.org/0000-0002-1865-7532"]},"institutions":[{"id":"https://openalex.org/I2800006345","display_name":"Leiden University Medical Center","ror":"https://ror.org/05xvt9f17","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2800006345"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"MICHEL P. M. VIERBOOM","raw_affiliation_strings":["Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, 2333ZA Leiden, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, 2333ZA Leiden, The Netherlands","institution_ids":["https://openalex.org/I2800006345"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041281028","display_name":"Sjoerd H. van der Burg","orcid":"https://orcid.org/0000-0002-6556-0354","observed_orcids":["https://orcid.org/0000-0002-6556-0354"]},"institutions":[{"id":"https://openalex.org/I2800006345","display_name":"Leiden University Medical Center","ror":"https://ror.org/05xvt9f17","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2800006345"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"SJOERD H. VAN DER BURG","raw_affiliation_strings":["Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, 2333ZA Leiden, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, 2333ZA Leiden, The Netherlands","institution_ids":["https://openalex.org/I2800006345"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111765943","display_name":"Lorne F. Erdile","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"LORNE ERDILE","raw_affiliation_strings":["Virogenetics Corporation, 465 Jordan Road, Troy, New York 12180, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Virogenetics Corporation, 465 Jordan Road, Troy, New York 12180, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5035565968","display_name":"Cornelis J.M. Melief","orcid":"https://orcid.org/0000-0001-5709-3584","observed_orcids":["https://orcid.org/0000-0001-5709-3584","https://orcid.org/0000-0003-0741-2094"]},"institutions":[{"id":"https://openalex.org/I2800006345","display_name":"Leiden University Medical Center","ror":"https://ror.org/05xvt9f17","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2800006345"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"CORNELIS J. M. MELIEF","raw_affiliation_strings":["Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, 2333ZA Leiden, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, 2333ZA Leiden, The Netherlands","institution_ids":["https://openalex.org/I2800006345"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5011701229"],"corresponding_institution_ids":["https://openalex.org/I2800006345"],"apc_list":{"value":5080,"currency":"USD","value_usd":5080},"apc_paid":null,"fwci":0.521,"has_fulltext":false,"cited_by_count":56,"citation_normalized_percentile":{"value":0.52852154,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"910","issue":"1","first_page":"223","last_page":"236"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":0.0031999999191612005,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.0019000000320374966,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/p53","display_name":"p53","score":0.9940000176429749},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.9160000085830688},{"id":"https://openalex.org/keywords/tp53-mutation","display_name":"TP53 mutation","score":0.6359999775886536},{"id":"https://openalex.org/keywords/tumor-antigens","display_name":"tumor antigens","score":0.37700000405311584},{"id":"https://openalex.org/keywords/mhc-class-ii-restriction","display_name":"MHC class II restriction","score":0.6759999990463257},{"id":"https://openalex.org/keywords/t-helper-cells","display_name":"T helper cells","score":0.6859999895095825},{"id":"https://openalex.org/keywords/self-tolerance","display_name":"self-tolerance","score":0.7979999780654907},{"id":"https://openalex.org/keywords/adoptive-immunotherapy","display_name":"adoptive immunotherapy","score":0.8149999976158142},{"id":"https://openalex.org/keywords/colon-cancer","display_name":"colon cancer","score":0.9200000166893005},{"id":"https://openalex.org/keywords/tumor-specific-peptides","display_name":"tumor-specific peptides","score":0.32100000977516174}],"concepts":[{"id":"https://openalex.org/C147969180","wikidata":"https://www.wikidata.org/wiki/Q5014579","display_name":"CTL*","level":4,"score":0.9491199254989624},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.7144976854324341},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.6366624236106873},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6120388507843018},{"id":"https://openalex.org/C170627219","wikidata":"https://www.wikidata.org/wiki/Q13218497","display_name":"MHC class I","level":4,"score":0.6027963757514954},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5754740834236145},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.5729005932807922},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.5641784071922302},{"id":"https://openalex.org/C207936829","wikidata":"https://www.wikidata.org/wiki/Q423163","display_name":"Major histocompatibility complex","level":3,"score":0.5104324221611023},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.47890961170196533},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.44656825065612793},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.4461266100406647},{"id":"https://openalex.org/C51785407","wikidata":"https://www.wikidata.org/wiki/Q2627568","display_name":"Effector","level":2,"score":0.42229360342025757},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.260562539100647},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.07480594515800476},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.06832477450370789}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000951","descriptor_name":"Antigens, Neoplasm","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D000951","descriptor_name":"Antigens, Neoplasm","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D009154","descriptor_name":"Mutation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D009374","descriptor_name":"Neoplasms, Experimental","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D009374","descriptor_name":"Neoplasms, Experimental","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D009374","descriptor_name":"Neoplasms, Experimental","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":false},{"descriptor_ui":"D016158","descriptor_name":"Genes, p53","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016159","descriptor_name":"Tumor Suppressor Protein p53","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D016159","descriptor_name":"Tumor Suppressor Protein p53","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1111/j.1749-6632.2000.tb06711.x","doi":"https://doi.org/10.1111/j.1749-6632.2000.tb06711.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1749-6632.2000.tb06711.x","pdf_url":null,"source":{"id":"https://openalex.org/S8802318","display_name":"Annals of the New York Academy of Sciences","issn_l":"0077-8923","issn":["0077-8923","1749-6632"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of the New York Academy of Sciences","raw_type":"journal-article"},{"id":"pmid:10911916","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10911916","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of the New York Academy of Sciences","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":45,"referenced_works":["https://openalex.org/W1501518736","https://openalex.org/W1556274289","https://openalex.org/W1669165205","https://openalex.org/W1678167583","https://openalex.org/W1838166837","https://openalex.org/W1838860459","https://openalex.org/W1967294666","https://openalex.org/W1968266972","https://openalex.org/W1977090800","https://openalex.org/W1983806918","https://openalex.org/W1984655584","https://openalex.org/W1987481543","https://openalex.org/W1988832652","https://openalex.org/W2000211211","https://openalex.org/W2007515141","https://openalex.org/W2010363127","https://openalex.org/W2025309264","https://openalex.org/W2033048285","https://openalex.org/W2033537986","https://openalex.org/W2040594411","https://openalex.org/W2041989092","https://openalex.org/W2042316019","https://openalex.org/W2049527615","https://openalex.org/W2056530510","https://openalex.org/W2058599151","https://openalex.org/W2063366670","https://openalex.org/W2065121753","https://openalex.org/W2074423119","https://openalex.org/W2078760290","https://openalex.org/W2083379652","https://openalex.org/W2095356554","https://openalex.org/W2107954314","https://openalex.org/W2110344966","https://openalex.org/W2116595225","https://openalex.org/W2121808021","https://openalex.org/W2123524669","https://openalex.org/W2126844355","https://openalex.org/W2127094135","https://openalex.org/W2130867278","https://openalex.org/W2138733343","https://openalex.org/W2147322289","https://openalex.org/W2147597038","https://openalex.org/W2149244682","https://openalex.org/W2154381385","https://openalex.org/W2170939558"],"related_works":["https://openalex.org/W2154539544","https://openalex.org/W2127094135","https://openalex.org/W7100249496","https://openalex.org/W1987155012","https://openalex.org/W2078894280","https://openalex.org/W83283937","https://openalex.org/W1556274289","https://openalex.org/W2161952857","https://openalex.org/W1967132844","https://openalex.org/W1972149015"],"abstract_inverted_index":{"Approximately":[0],"50%":[1],"of":[2,11,22,32,52,64,70,88,94,122,144,156,182,192,207,252],"all":[3],"human":[4],"malignancies":[5],"exhibit":[6],"mutation":[7],"and":[8,173,189,230,242],"aberrant":[9],"expression":[10,87],"p53,":[12,89],"making":[13],"this":[14,138],"protein":[15],"an":[16],"interesting":[17],"candidate":[18],"target":[19],"for":[20,97,137,178,211],"immunotherapy":[21,51],"cancer.":[23],"Mutations":[24],"in":[25,62,67,148,186,237,243],"p53":[26,37,46,218],"are":[27,109,234],"highly":[28],"diverse.":[29],"Therefore,":[30],"targeting":[31],"determinants":[33],"within":[34],"the":[35,43,68,92,103,118,157,179,187,193],"wild-type":[36],"sequence":[38],"appears":[39],"most":[40],"practical.":[41],"Despite":[42],"fact":[44],"that":[45,81,91,199],"is":[47,100,176,223],"ubiquitously":[48],"expressed,":[49],"adoptive":[50],"tumor-bearing":[53],"mice":[54],"with":[55],"p53-specific":[56,98,127,158,250],"cytotoxic":[57],"T":[58,152],"lymphocytes":[59],"(CTL)":[60],"results":[61],"eradication":[63],"p53-overexpressing":[65,221],"tumors":[66,80,96,198,222],"absence":[69],"immunopathological":[71],"damage":[72],"to":[73,164],"normal":[74],"tissues.":[75],"These":[76],"CTL":[77,99,128,147],"also":[78,196],"eliminate":[79],"do":[82],"not":[83,162],"show":[84],"greatly":[85],"enhanced":[86],"indicating":[90],"sensitivity":[93],"these":[95],"determined":[101],"by":[102,105,117,168],"efficiency":[104],"which":[106],"p53-derived":[107],"peptides":[108],"processed":[110],"into":[111],"class":[112,201,215],"I":[113,246],"MHC,":[114],"rather":[115],"than":[116],"steady":[119],"state":[120],"levels":[121],"p53.":[123],"Of":[124],"note,":[125],"although":[126],"can":[129],"readily":[130],"be":[131,165],"isolated":[132],"from":[133],"p53-/-":[134],"mice,":[135],"tolerance":[136],"self":[139],"antigen":[140],"may":[141],"prevent":[142],"induction":[143,188],"similarly":[145],"effective":[146],"p53+/+":[149],"subjects.":[150],"The":[151,205],"helper":[153],"(Th)":[154],"branch":[155],"immune":[159],"response":[160],"does":[161],"seem":[163],"profoundly":[166],"affected":[167],"tolerance.":[169],"In":[170,227],"addition,":[171,228],"more":[172,174],"evidence":[175],"obtained":[177],"pivotal":[180],"role":[181],"tumor-specific":[183],"Th":[184,208,232],"cells":[185],"effector":[190],"phases":[191],"antitumor":[194],"response,":[195],"against":[197,220],"lack":[200],"II":[202,216],"MHC":[203],"expression.":[204],"efficacy":[206],"cells,":[209],"specific":[210],"a":[212,238,244],"recently":[213],"identified":[214],"MHC-restricted":[217],"peptide,":[219],"currently":[224],"being":[225],"investigated.":[226],"natural":[229],"induced":[231],"responses":[233],"analyzed":[235],"both":[236],"murine":[239],"tumor":[240],"model":[241],"phase":[245],"clinical":[247],"trial":[248],"involving":[249],"vaccination":[251],"colon":[253],"cancer":[254],"patients.":[255]},"counts_by_year":[{"year":2020,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}